Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Seoul National University Hospital

Verified

Basic Information

Site Overview

Source: Human-provided.

Seoul National University Hospital (SNUH) is a leading academic and national central hospital in South Korea, located at 101 Daehak-ro, Jongno-gu, Seoul. Established from Jejungwon in 1885, SNUH provides advanced medical care across critical and essential healthcare areas while serving as a major center for medical education, research, and clinical training. The hospital has more than 1,600 inpatient beds and over 8,500 employees, including doctors, nurses, pharmacists, and medical technologists. SNUH also operates a broader healthcare network that includes its Children’s Hospital, Cancer Hospital, Bundang Hospital, Boramae Hospital, and other affiliated institutions. Its research activities span clinical research, advanced biotechnology, digital health, and medical innovation, making it a significant institution for clinical trials and international healthcare collaboration

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Hospital
Source: Trial-derived.
240Total Trials
Source: Trial-derived.
56Recruiting Trials
Source: Trial-derived.
102Active Trials
Source: Trial-derived.
115Completed Trials
Source: Trial-derived.
302Unique Conditions
Source: Trial-derived.
132Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Breast Cancer (10)Source: Trial-derived. Ovarian Cancer (8)Source: Trial-derived. Breast Neoplasms (7)Source: Trial-derived. Colorectal Cancer (6)Source: Trial-derived. Advanced Solid Tumors (5)Source: Trial-derived. Non-small Cell Lung Cancer (5)Source: Trial-derived. Small Cell Lung Cancer (5)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (4)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (95)Source: Trial-derived. AbbVie (31)Source: Trial-derived. Seoul National University Hospital (30)Source: Trial-derived. Daiichi Sankyo (9)Source: Trial-derived. Eisai Inc. (9)Source: Trial-derived. European Network of Gynaecological Oncological Trial Groups (ENGOT) (5)Source: Trial-derived. Pfizer (5)Source: Trial-derived. Bayer (4)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Echocardiography
Source: AI-inferred. Spirometry
Source: AI-inferred. Six-minute walk test

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Circulating tumour DNA testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Intravesical instillation therapy
Source: AI-inferred. Ambulatory 24-hour objective cough monitoring
Source: AI-inferred. Blood glucose meter testing
Source: AI-inferred. CD19-positive B-cell enumeration
Source: AI-inferred. Computerised cognitive assessment battery
Source: AI-inferred. Contrast-enhanced tumour imaging
Source: AI-inferred. Cytogenetic analysis
Source: AI-inferred. Diabetic retinopathy screening eye examination